Stock Snapshot from
Dr Reddy's Laboratories LtdAdd to My Watchlist
RDY:USNew YorkIndustry: Medical-Drugs
- 37.52Last
- 0.20 0.54%Today's Change
- 37.32Previous Close
- 52 Week Low - High
Earnings
| EPS: Year Actual ttm | -- |
| EPS: Year Est. 3/14 ttm | 111.011 |
| EPS: Quarterly Actual 3/13 | 0.00 |
| EPS: Quarterly Est. 6/13 | 24.06 |
| Price/Earnings ttm | -- |
| Relative Price/Earnings | -- |
| Earnings Growth Rate | 28.73 |
Company Description
| Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company also manufactures and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The Company markets its products in India and around the world. | |
| Revenue | $116 billion |
| Net Income | $17 billion |
| Total Assets | $142 billion |
| Employees | 14,500 |
| Web Site | www.drreddys.com |
Latest Headlines
No news available.
Watchlist
Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.
